Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
16
self-reported 11–50 band
Founded
2009
17 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
2
Series unknown · Jul 2018 · US$ 4.8M
Company type
Public Company
self-reported
Description
Biolidics – Bringing clarity to cancer
Biolidics Ltd, formerly known as Clearbridge BioMedics, is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.
Biolidics has developed patented technology and solutions with the potential to serve as a platform technology for the diagnosis, prognosis, treatment selection and treatment monitoring of various types of cancers.
The ClearCell® FX1 System by Biolidics is a fully automated CE-IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patient's body.
Our patented award-winning microfluidic technologies have many applications throughout the various stages of a patient's cancer journey, from cancer screening and staging to personalised treatment, and post-cancer monitoring.
The ClearCell® FX1 System has been installed in academic and research institutes, hospitals and laboratories across the world, including Singapore, China, Hong Kong, Japan, the US and certain EU countries.
Biolidics is a spin-off from the National University of Singapore (NUS) / SMART MIT and is the first incubatee of Clearbridge Accelerator, a high-technology incubator backed by the Singapore Government’s National Research Foundation (NRF).
For more information, please visit www.biolidics.com.
Specialties
All 6 specialties
- Liquid Biopsy
- Circulating Tumor Cells
- Microfluidics
- Cancer
- Biotechnology
- Medical Device
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG37 Jalan Pemimpin; #02-07 Mapex; Singapore, 577177Primary
Grid intelligence Members
Funding
Last round · 28 July 2018US$ 4.8MSeries unknown
Rounds2
Round typeSeries unknown · venture round
Amount (USD)4,800,000
Stage ranknot recorded
Investors named0
Since last round7 yr 5 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2009 to 2026 |
| Series unknown · 28 Jul 2018 | US$ 4.8M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Biolidics Limited (Formerly known as Clearbridge BioMedics)?
The record holds 16 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Biolidics Limited (Formerly known as Clearbridge BioMedics) have offices?
One address on record, Singapore only. Primary: 37 Jalan Pemimpin, #02-07 Mapex, Singapore 577177.
Has Biolidics Limited (Formerly known as Clearbridge BioMedics) raised funding?
Two rounds. Latest 28 July 2018: Series unknown, US$4,800,000.
What does this brand list as its specialties?
Six tags on the brand's own list, among them cancer, biotechnology and medical device.
Which companies are listed alongside this brand?
3 profiles list Biolidics Limited (Formerly known as Clearbridge BioMedics) as a peer — 62nd percentile in Medical Equipment Manufacturing. It lists ten peers of its own. Veredus Laboratories lists it back.